Ian is a Partner in PwC’s Pharmaceutical Advisory Practice and has been working in the BioPharmaceutical industry focused on Clinical Development for the past eighteen years. Ian joined PwC in 2019 and is focusing on global clinical development business transformation enabled by digital technologies. Ian is a molecular biologist by education and received his undergraduate degree from the University of California, Santa Cruz in 1999. After working for a year as a research associate for both a reference laboratory and start-up biotechnology company, he took an position with Amgen’s Clinical Development organization in Thousand Oaks, CA in 2000. Ian had multiple responsibilities at Amgen, including clinical trial operations, regional monitoring, data management, CRO/vendor management, and investigator clinical trial agreements and reimbursements. While at Amgen, Ian worked on multiple biologics license applications and clinical study report submissions, primarily in rheumatology. Ian also supported several internal technology projects at Amgen, including the industry’s first implementation of Siebel as a Clinical Trial Management System, where he served a subject matter expert in clinical trial budgets, forecasts, and investigator reimbursements. In 2001, excited by the prospects of working for startup technology company, Ian joined Medidata Solutions at the 14th employee and moved from Los Angeles, CA to New York, NY. During his 4 year tenure at Medidata, Ian performed many different responsibilities, including client account management, pre-sales, program/project management, technology/knowledge transfer, and study esign / build. In 2004, Ian moved to London, UK as one of the first international employees supporting the initial accounts/projects, as well as the build-out of the UK office. After returning to New York in 2005, Ian took on an internal role transforming Medidata’s professional services operating model, which included organizational and quality management system design, roles/responsibilities, policies, standard operating procedures, work instructions, and business processes. In 2006, excited about continuing to expand and refine his business transformation experience, Ian joined Accenture’s Pharma R&D practice as a Manager. During Ian’s 12.5 years at Accenture, he took on increasing levels of responsibility and was promoted to Managing Director in 2014. When Ian left Accenture, he was accountable for the Clinical Domain, 1 of the 4 vertical domains R&D practice, where he developed go-to-market strategies across 4 lines of business at Accenture (Strategy, Consulting, Operations, and Digital) as well as the Global R&D Account Lead at multiple major biopharmaceutical companies. Ian’s project experience includes business strategy/roadmap development, operating model design, business case development, global digital business transformation, technology selection and implementation, business process design, change management, and SDLC management. Ian’s functional focus spanned program/protocol design, study start-up, clinical trial operations, data management, analysis and reporting, and submissions and has led 40+ major transformational programs during his career where 5+ where $100m capital investments.